GlassScriptPhysician profile
Pavlo Kolyesnykov
NPI 1770213266
$4,747.48
in general payments reported to CMS, 2019-2025
11 companies · $2,469 in 2025
The $2,469 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $732 · 2024: $1,546 · 2025: $2,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,922 · Travel and Lodging: $477 · Education: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,921.50 |
| Travel and Lodging | $476.50 |
| Education | $349.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,883.94 | 2023-2025 | Dart-Fire, Prophecy, Variax |
| Medshape, INC. | $636.62 | 2025 | Dynanail, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Kerecis Limited | $499.82 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $426.55 | 2023-2025 | Stravix Mesh, Grafix Pl, Pico |
| Medical Device Business Services, INC. | $349.48 | 2024 | |
| Depuy Synthes Sales INC. | $319.03 | 2024-2025 | Motoband, Na, Fibergraft Aeridyan Matrix |
| Sioux Surgical INC | $237.92 | 2024-2025 | |
| Davol INC. | $147.80 | 2025 | Arista |
| Novastep INC. | $112.66 | 2025 | Nexis |
| Linvatec Corporation | $110.93 | 2025 | Neospan |
| Paragon 28, INC. | $22.73 | 2025 | Phantom Fibula Nail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavlo Kolyesnykov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.